| 1 | healthy | 29,862 |
| 2 | endurance-trained | 56 |
| 3 | resistance-trained | 51 |
| 4 | randomly-selected | 23 |
| 5 | marijuana-dependent | 21 |
| 6 | non-patient | 14 |
| 7 | postlingually | 14 |
| 8 | non-heat-acclimated | 13 |
| 9 | pre-adolescent | 13 |
| 10 | non-late-life | 12 |
| 11 | malaria-naïve | 7 |
| 12 | random-source | 7 |
| 13 | shirsha | 7 |
| 14 | healty | 6 |
| 15 | neophyte | 6 |
| 16 | non-ckdu | 6 |
| 17 | non-eoe | 6 |
| 18 | nonacclimated | 6 |
| 19 | nonhysterectomized | 6 |
| 20 | opioid-injecting | 6 |
| 21 | dip-ex | 5 |
| 22 | dorzolamide-treated | 5 |
| 23 | ldhiv | 5 |
| 24 | non-athletic | 5 |
| 25 | per-mag | 5 |
| 26 | ptz-kindled | 5 |
| 27 | similar-aged | 5 |
| 28 | 10,101 | 4 |
| 29 | 14-d-old | 4 |
| 30 | 65-75-year-old | 4 |
| 31 | 9-mo-old | 4 |
| 32 | club-level | 4 |
| 33 | dnb-exposed | 4 |
| 34 | ei-group | 4 |
| 35 | etec-naïve | 4 |
| 36 | males/10 | 4 |
| 37 | multitalker | 4 |
| 38 | non-hysterectomy | 4 |
| 39 | non-travelling | 4 |
| 40 | nonmaltreated | 4 |
| 41 | otherwise-healthy | 4 |
| 42 | r53r | 4 |
| 43 | sodium-depleted | 4 |
| 44 | spider-fearful | 4 |
| 45 | time-dated | 4 |
| 46 | 4221 | 3 |
| 47 | acth-sufficient | 3 |
| 48 | bromocriptine-qr-treated | 3 |
| 49 | cart-naive | 3 |
| 50 | d-mph-treated | 3 |
| 51 | demographically-matched | 3 |
| 52 | exposure-to-secondhand-smoke | 3 |
| 53 | hbv-seronegative | 3 |
| 54 | kezhuohou | 3 |
| 55 | kulun | 3 |
| 56 | leptin-sensitive | 3 |
| 57 | lllt-treated | 3 |
| 58 | male/7 | 3 |
| 59 | mtb-infected | 3 |
| 60 | niacin-treated | 3 |
| 61 | nonabstaining | 3 |
| 62 | peanut-allergic | 3 |
| 63 | saline-infused | 3 |
| 64 | social-drinking | 3 |
| 65 | tick-infested | 3 |
| 66 | trichomonas-free | 3 |
| 67 | younger-old | 3 |
| 68 | 10,486 | 2 |
| 69 | 11.114 | 2 |
| 70 | 11498 | 2 |
| 71 | 12-kg | 2 |
| 72 | 12-to | 2 |
| 73 | 15,150 | 2 |
| 74 | 15,261 | 2 |
| 75 | 16,154 | 2 |
| 76 | 17-day-old | 2 |
| 77 | 2,872 | 2 |
| 78 | 22-d-old | 2 |
| 79 | 245,610 | 2 |
| 80 | 2526 | 2 |
| 81 | 3,258 | 2 |
| 82 | 3,898 | 2 |
| 83 | 35-day-old | 2 |
| 84 | 3745 | 2 |
| 85 | 3798 | 2 |
| 86 | 4,574 | 2 |
| 87 | 4-wk-old | 2 |
| 88 | 4461 | 2 |
| 89 | 59,000 | 2 |
| 90 | 6605 | 2 |
| 91 | 6899 | 2 |
| 92 | 7286 | 2 |
| 93 | 7983 | 2 |
| 94 | 8581 | 2 |
| 95 | ad5-seronegative | 2 |
| 96 | ams-resistant | 2 |
| 97 | apparently-healthy | 2 |
| 98 | avanafil-treated | 2 |
| 99 | bss-treated | 2 |
| 100 | cases/33 | 2 |
| 101 | cholesterol-managing | 2 |
| 102 | clinic-care | 2 |
| 103 | community-matched | 2 |
| 104 | cpi-1189-treated | 2 |
| 105 | cyp3a4*1/*1b | 2 |
| 106 | delayed-switch | 2 |
| 107 | dif-treated | 2 |
| 108 | egg-sensitive | 2 |
| 109 | freshly-extracted | 2 |
| 110 | grass-allergic | 2 |
| 111 | h-imbibed | 2 |
| 112 | hape-susceptible | 2 |
| 113 | hazardous-drinking | 2 |
| 114 | hbv-seropositive | 2 |
| 115 | hyperfibrinogenaemic | 2 |
| 116 | kupat | 2 |
| 117 | latino-american | 2 |
| 118 | male/23 | 2 |
| 119 | male/9 | 2 |
| 120 | males/26 | 2 |
| 121 | males/7 | 2 |
| 122 | males/8 | 2 |
| 123 | mavrilimumab-treated | 2 |
| 124 | mbl-hcv1-treated | 2 |
| 125 | men/27 | 2 |
| 126 | mosquito-bite-sensitive | 2 |
| 127 | non-all | 2 |
| 128 | non-ehs | 2 |
| 129 | non-hyperlipidaemic | 2 |
| 130 | non-insulin-resistant | 2 |
| 131 | non-minos | 2 |
| 132 | non-ow | 2 |
| 133 | non-screen | 2 |
| 134 | nonmosaic | 2 |
| 135 | osteopenic/osteoporotic | 2 |
| 136 | overtrained | 2 |
| 137 | pegaptanib-treated | 2 |
| 138 | periodontitis-free | 2 |
| 139 | pgz-treated | 2 |
| 140 | pib-negative | 2 |
| 141 | pramipexole-treated | 2 |
| 142 | preobese | 2 |
| 143 | protocol-adherent | 2 |
| 144 | rate-matched | 2 |
| 145 | ready-to-emerge | 2 |
| 146 | region-matched | 2 |
| 147 | rhinovirus-infected | 2 |
| 148 | shep-treated | 2 |
| 149 | sodium-repleted | 2 |
| 150 | speech-anxious | 2 |
| 151 | tajik | 2 |
| 152 | undialysed | 2 |
| 153 | unsexed | 2 |
| 154 | women/4 | 2 |
| 155 | yr-old | 2 |
| 156 | zonisamide-treated | 2 |
| 157 | °c-acclimated | 2 |
| 158 | 'lowering | 1 |
| 159 | ,986 | 1 |
| 160 | 0676 | 1 |
| 161 | 1,129,025 | 1 |
| 162 | 1,790,241 | 1 |
| 163 | 1,913,925 | 1 |
| 164 | 10,229 | 1 |
| 165 | 10,462 | 1 |
| 166 | 10,463 | 1 |
| 167 | 10,672 | 1 |
| 168 | 10,756 | 1 |
| 169 | 10,814 | 1 |
| 170 | 106,406 | 1 |
| 171 | 11,116 | 1 |
| 172 | 11,554 | 1 |
| 173 | 11.5-y-old | 1 |
| 174 | 114,999 | 1 |
| 175 | 119,151 | 1 |
| 176 | 11914 | 1 |
| 177 | 12,463 | 1 |
| 178 | 12,903 | 1 |
| 179 | 12058 | 1 |
| 180 | 121,081 | 1 |
| 181 | 122/291 | 1 |
| 182 | 13,045 | 1 |
| 183 | 13,277 | 1 |
| 184 | 13,444 | 1 |
| 185 | 13,770 | 1 |
| 186 | 13/198 | 1 |
| 187 | 135,715 | 1 |
| 188 | 136,720 | 1 |
| 189 | 14,571 | 1 |
| 190 | 14,762 | 1 |
| 191 | 14,965 | 1 |
| 192 | 145,007 | 1 |
| 193 | 15,005 | 1 |
| 194 | 15,366 | 1 |
| 195 | 15,419 | 1 |
| 196 | 153,996 | 1 |
| 197 | 154899 | 1 |
| 198 | 15910 | 1 |
| 199 | 16,856 | 1 |
| 200 | 16,876 | 1 |
| 201 | 162,576 | 1 |
| 202 | 166,755 | 1 |
| 203 | 16608 | 1 |
| 204 | 17,852 | 1 |
| 205 | 17/394 | 1 |
| 206 | 17/490 | 1 |
| 207 | 170/185 | 1 |
| 208 | 174,120 | 1 |
| 209 | 176,441 | 1 |
| 210 | 176/325 | 1 |
| 211 | 176/345 | 1 |
| 212 | 18,348 | 1 |
| 213 | 18,403 | 1 |
| 214 | 18,558 | 1 |
| 215 | 18,748 | 1 |
| 216 | 18,978 | 1 |
| 217 | 188,934 | 1 |
| 218 | 19,522 | 1 |
| 219 | 19,596 | 1 |
| 220 | 19,961 | 1 |
| 221 | 193,372 | 1 |
| 222 | 2,061 | 1 |
| 223 | 2,196 | 1 |
| 224 | 2,279 | 1 |
| 225 | 2,767 | 1 |
| 226 | 2-month-to | 1 |
| 227 | 20,076 | 1 |
| 228 | 20,360 | 1 |
| 229 | 20,742 | 1 |
| 230 | 20,746 | 1 |
| 231 | 202,517 | 1 |
| 232 | 21,268 | 1 |
| 233 | 21,959 | 1 |
| 234 | 216,400 | 1 |
| 235 | 22,604 | 1 |
| 236 | 22,896 | 1 |
| 237 | 223,336 | 1 |
| 238 | 226,877 | 1 |
| 239 | 23,508 | 1 |
| 240 | 23,661 | 1 |
| 241 | 232515 | 1 |
| 242 | 24,523 | 1 |
| 243 | 24,529 | 1 |
| 244 | 24,976 | 1 |
| 245 | 24-overweight/obese | 1 |
| 246 | 25-wk-old | 1 |
| 247 | 25.08/100,000 | 1 |
| 248 | 26,224 | 1 |
| 249 | 26,272 | 1 |
| 250 | 26,599 | 1 |
| 251 | 26,703 | 1 |
| 252 | 26.18/100,000 | 1 |
| 253 | 261248 | 1 |
| 254 | 27,341 | 1 |
| 255 | 274,135 | 1 |
| 256 | 28,583 | 1 |
| 257 | 28,997 | 1 |
| 258 | 280/349 | 1 |
| 259 | 280000 | 1 |
| 260 | 282,875 | 1 |
| 261 | 285,864 | 1 |
| 262 | 29,012 | 1 |
| 263 | 29,265 | 1 |
| 264 | 29,579 | 1 |
| 265 | 29,978 | 1 |
| 266 | 3,142 | 1 |
| 267 | 3,306 | 1 |
| 268 | 3,348 | 1 |
| 269 | 3,408 | 1 |
| 270 | 3,619 | 1 |
| 271 | 3,836 | 1 |
| 272 | 3.574 | 1 |
| 273 | 3/392 | 1 |
| 274 | 30,285 | 1 |
| 275 | 322/384 | 1 |
| 276 | 33,505 | 1 |
| 277 | 34,003 | 1 |
| 278 | 35-50-year-old | 1 |
| 279 | 35-week-old | 1 |
| 280 | 35/62 | 1 |
| 281 | 36,214 | 1 |
| 282 | 3651 | 1 |
| 283 | 368/1012 | 1 |
| 284 | 4,139 | 1 |
| 285 | 4,441 | 1 |
| 286 | 4,718 | 1 |
| 287 | 4,730 | 1 |
| 288 | 4,735 | 1 |
| 289 | 40,410 | 1 |
| 290 | 40-67-year-old | 1 |
| 291 | 4151 | 1 |
| 292 | 42,223 | 1 |
| 293 | 431,718 | 1 |
| 294 | 44/91 | 1 |
| 295 | 4453 | 1 |
| 296 | 453,965 | 1 |
| 297 | 46,836 | 1 |
| 298 | 488,909 | 1 |
| 299 | 49,479 | 1 |
| 300 | 492,530 | 1 |
| 301 | 5,411 | 1 |
| 302 | 5,447 | 1 |
| 303 | 5,676 | 1 |
| 304 | 5,712 | 1 |
| 305 | 5,808 | 1 |
| 306 | 5,836 | 1 |
| 307 | 5,864 | 1 |
| 308 | 5,909 | 1 |
| 309 | 5,975 | 1 |
| 310 | 50,219 | 1 |
| 311 | 50,252 | 1 |
| 312 | 51,230 | 1 |
| 313 | 5179 | 1 |
| 314 | 55,072 | 1 |
| 315 | 57,143 | 1 |
| 316 | 57,499 | 1 |
| 317 | 57,952 | 1 |
| 318 | 58,228 | 1 |
| 319 | 6,085 | 1 |
| 320 | 6,278 | 1 |
| 321 | 6,520 | 1 |
| 322 | 6,545 | 1 |
| 323 | 6,583 | 1 |
| 324 | 6,708 | 1 |
| 325 | 6,871 | 1 |
| 326 | 60/162 | 1 |
| 327 | 607/624 | 1 |
| 328 | 6129 | 1 |
| 329 | 6222 | 1 |
| 330 | 63,624 | 1 |
| 331 | 6440 | 1 |
| 332 | 66,450 | 1 |
| 333 | 6693 | 1 |
| 334 | 67,471 | 1 |
| 335 | 68,412 | 1 |
| 336 | 68,954 | 1 |
| 337 | 69,395 | 1 |
| 338 | 7,120 | 1 |
| 339 | 7,161 | 1 |
| 340 | 7,478 | 1 |
| 341 | 7,594 | 1 |
| 342 | 7,753 | 1 |
| 343 | 7168 | 1 |
| 344 | 7196 | 1 |
| 345 | 7210 | 1 |
| 346 | 7290 | 1 |
| 347 | 73-y-old | 1 |
| 348 | 7389 | 1 |
| 349 | 7569 | 1 |
| 350 | 77,447 | 1 |
| 351 | 7744 | 1 |
| 352 | 8,791 | 1 |
| 353 | 8,891 | 1 |
| 354 | 8,929 | 1 |
| 355 | 8,991 | 1 |
| 356 | 81918 | 1 |
| 357 | 82,553 | 1 |
| 358 | 83,140 | 1 |
| 359 | 84,394 | 1 |
| 360 | 8407 | 1 |
| 361 | 8448 | 1 |
| 362 | 847,982 | 1 |
| 363 | 8731 | 1 |
| 364 | 8802 | 1 |
| 365 | 8938 | 1 |
| 366 | 9,497 | 1 |
| 367 | 9,668 | 1 |
| 368 | 9,959 | 1 |
| 369 | 9/195 | 1 |
| 370 | 91,588 | 1 |
| 371 | 91,627 | 1 |
| 372 | 922/301 | 1 |
| 373 | 9393 | 1 |
| 374 | 94,808 | 1 |
| 375 | 9471 | 1 |
| 376 | 95,038 | 1 |
| 377 | 95,598 | 1 |
| 378 | 9528 | 1 |
| 379 | 9573 | 1 |
| 380 | 9690 | 1 |
| 381 | 97,486 | 1 |
| 382 | 98,093 | 1 |
| 383 | 9928 | 1 |
| 384 | active-dosed | 1 |
| 385 | aed-treated | 1 |
| 386 | age-marched | 1 |
| 387 | age-menopause-matched | 1 |
| 388 | alcohol-dependent/abusing | 1 |
| 389 | amygdala-implanted | 1 |
| 390 | anthocyanin-treated | 1 |
| 391 | anti-hbc-positive/hbsag-negative | 1 |
| 392 | artificially-inseminated | 1 |
| 393 | aspirin-naïve | 1 |
| 394 | atdh-free | 1 |
| 395 | atg/g-csf-treated | 1 |
| 396 | atropine-injected | 1 |
| 397 | attention/relaxation | 1 |
| 398 | attestable | 1 |
| 399 | average-height | 1 |
| 400 | bcp-treated | 1 |
| 401 | bed-confined | 1 |
| 402 | benralizumab-treated | 1 |
| 403 | bgg492-treated | 1 |
| 404 | biojector-primed | 1 |
| 405 | bisphosphonate-naïve | 1 |
| 406 | black-skinned | 1 |
| 407 | bms-986001-treated | 1 |
| 408 | bone-health-related | 1 |
| 409 | boys/31 | 1 |
| 410 | boys/34 | 1 |
| 411 | boys/nine | 1 |
| 412 | bpd/adhd | 1 |
| 413 | btx-a-naive | 1 |
| 414 | bvdv-naïve | 1 |
| 415 | bzp/tfmpp-only | 1 |
| 416 | caesarean-delivered | 1 |
| 417 | cases/1,543 | 1 |
| 418 | cases/1,682 | 1 |
| 419 | cases/1119 | 1 |
| 420 | cases/30 | 1 |
| 421 | cases/436 | 1 |
| 422 | cases/575 | 1 |
| 423 | cases/60 | 1 |
| 424 | cases/66 | 1 |
| 425 | cases/676 | 1 |
| 426 | cases/778 | 1 |
| 427 | cav3dn-expressing | 1 |
| 428 | cbs-treated | 1 |
| 429 | ccnd1-amplified | 1 |
| 430 | cg-ss | 1 |
| 431 | chlamydial-infected | 1 |
| 432 | club-standard | 1 |
| 433 | co-analyze | 1 |
| 434 | colour-matched | 1 |
| 435 | cq-treated | 1 |
| 436 | crash-involved | 1 |
| 437 | creatine-supplemented | 1 |
| 438 | ctx/met-treated | 1 |
| 439 | daily-smoking | 1 |
| 440 | detecting/treating | 1 |
| 441 | dhea-supplemented | 1 |
| 442 | diagnoses/all | 1 |
| 443 | dyslipidaemia-free | 1 |
| 444 | dyslipidemia-free | 1 |
| 445 | e-zes-treated | 1 |
| 446 | ergoferon-treated | 1 |
| 447 | eusplenic | 1 |
| 448 | euthyreoid | 1 |
| 449 | evening-healthy | 1 |
| 450 | ewes/ten | 1 |
| 451 | ex101-treated | 1 |
| 452 | female/10 | 1 |
| 453 | female/11 | 1 |
| 454 | female/14 | 1 |
| 455 | female/15 | 1 |
| 456 | female/21 | 1 |
| 457 | female/27 | 1 |
| 458 | female/51 | 1 |
| 459 | female/58 | 1 |
| 460 | female:33 | 1 |
| 461 | females/11 | 1 |
| 462 | females/14 | 1 |
| 463 | females/20 | 1 |
| 464 | females/5 | 1 |
| 465 | females/50 | 1 |
| 466 | fo-treated | 1 |
| 467 | fp-resistant | 1 |
| 468 | freeliving | 1 |
| 469 | fungi-free | 1 |
| 470 | gaa-supplemented | 1 |
| 471 | gc-treated | 1 |
| 472 | gender-equity-promoting | 1 |
| 473 | genistein-administered | 1 |
| 474 | girls/15 | 1 |
| 475 | girls/17 | 1 |
| 476 | group-48 | 1 |
| 477 | haemoglobin-a | 1 |
| 478 | havh-positive | 1 |
| 479 | hdm-sensitized | 1 |
| 480 | healthy-matched | 1 |
| 481 | heathy | 1 |
| 482 | hetg-positive | 1 |
| 483 | hg-treated | 1 |
| 484 | high-absorbency | 1 |
| 485 | highly-motivated | 1 |
| 486 | hla-a2+ | 1 |
| 487 | hsv-2-serodiscordant | 1 |
| 488 | hsv-2/hiv-1-coinfected | 1 |
| 489 | huma | 1 |
| 490 | humans.forty-two | 1 |
| 491 | hypertensive/diabetic | 1 |
| 492 | hypoergic | 1 |
| 493 | identity-seeking | 1 |
| 494 | igeκ-occupied | 1 |
| 495 | igg3-ia-positive | 1 |
| 496 | int2d | 1 |
| 497 | internationally-ranked | 1 |
| 498 | intramuscular-treated | 1 |
| 499 | ivm-treated | 1 |
| 500 | jhs | 1 |
| 501 | jianyang | 1 |
| 502 | kgf-treated | 1 |
| 503 | labyrinthine-defective | 1 |
| 504 | language-matched | 1 |
| 505 | late/ | 1 |
| 506 | lexaptepid-treated | 1 |
| 507 | light/non-drinking | 1 |
| 508 | low-compliant | 1 |
| 509 | low-psa | 1 |
| 510 | low-self-deceptive | 1 |
| 511 | macitentan-treated | 1 |
| 512 | male/11 | 1 |
| 513 | male/13 | 1 |
| 514 | male/14 | 1 |
| 515 | male/31 | 1 |
| 516 | male/eight | 1 |
| 517 | male/six | 1 |
| 518 | male:31 | 1 |
| 519 | males,18 | 1 |
| 520 | males,41 | 1 |
| 521 | males/12 | 1 |
| 522 | males/13 | 1 |
| 523 | males/16 | 1 |
| 524 | males/18 | 1 |
| 525 | males/23 | 1 |
| 526 | males/24 | 1 |
| 527 | males/37 | 1 |
| 528 | males/40 | 1 |
| 529 | males/45 | 1 |
| 530 | males/5 | 1 |
| 531 | males/9 | 1 |
| 532 | males/nine | 1 |
| 533 | males/thirteen | 1 |
| 534 | males:14 | 1 |
| 535 | matched-healthy | 1 |
| 536 | meal-fed | 1 |
| 537 | medi-534-vaccinated | 1 |
| 538 | medication-nonadherent | 1 |
| 539 | micrograms-treated | 1 |
| 540 | mitraclip-treated | 1 |
| 541 | mk-3641-treated | 1 |
| 542 | murid | 1 |
| 543 | naft-1-treated | 1 |
| 544 | negative-emotion | 1 |
| 545 | neighborhood-and-age-matched | 1 |
| 546 | neutral/beneficial | 1 |
| 547 | niacin-naïve | 1 |
| 548 | nineteen-year-old | 1 |
| 549 | no-memory | 1 |
| 550 | no-psychopathology | 1 |
| 551 | non-abruption | 1 |
| 552 | non-bd | 1 |
| 553 | non-dandruff | 1 |
| 554 | non-fever | 1 |
| 555 | non-firefighting | 1 |
| 556 | non-hypercapnic | 1 |
| 557 | non-ics-using | 1 |
| 558 | non-invited | 1 |
| 559 | non-lda | 1 |
| 560 | non-marsupial | 1 |
| 561 | non-neurotic | 1 |
| 562 | non-oil-yielding | 1 |
| 563 | non-pfo | 1 |
| 564 | non-pl | 1 |
| 565 | non-rhinitic | 1 |
| 566 | non-thrombocytopenic | 1 |
| 567 | non-vgp | 1 |
| 568 | nonhypercholesterolaemic | 1 |
| 569 | nonhyperresponsive | 1 |
| 570 | nonobesed | 1 |
| 571 | nonorthodontic | 1 |
| 572 | nonpolyhydramnios | 1 |
| 573 | nonsinger | 1 |
| 574 | nonstrabismic | 1 |
| 575 | nontraveling | 1 |
| 576 | nontumor-bearing | 1 |
| 577 | normal-sighted | 1 |
| 578 | normoleptinaemic | 1 |
| 579 | normotensive/pre-hypertensive | 1 |
| 580 | oc+ | 1 |
| 581 | oculo-visually | 1 |
| 582 | older/hyposmic | 1 |
| 583 | older/longer | 1 |
| 584 | op-exposed | 1 |
| 585 | osteiporotic | 1 |
| 586 | over-65-year-old | 1 |
| 587 | para-suicidal | 1 |
| 588 | parolee | 1 |
| 589 | participants-12 | 1 |
| 590 | patients/11 | 1 |
| 591 | patients/12 | 1 |
| 592 | patients/31 | 1 |
| 593 | percent.the | 1 |
| 594 | periodontally-healthy | 1 |
| 595 | periodontitis-affected | 1 |
| 596 | physically-inactive | 1 |
| 597 | plants-using | 1 |
| 598 | polysomnography-monitored | 1 |
| 599 | poorly-specified | 1 |
| 600 | post-cea | 1 |
| 601 | post-coronary-bypass | 1 |
| 602 | prelingually | 1 |
| 603 | preschool/early | 1 |
| 604 | prevalent-hemodialysis | 1 |
| 605 | proban-treated | 1 |
| 606 | r-hprl-treated | 1 |
| 607 | r-trained | 1 |
| 608 | rasburicase-treated | 1 |
| 609 | rcts,3097 | 1 |
| 610 | rearfoot-strike | 1 |
| 611 | recreationally-trained | 1 |
| 612 | resistant/relapsed | 1 |
| 613 | rhsod-treated | 1 |
| 614 | rotation-susceptible | 1 |
| 615 | rsp-treated | 1 |
| 616 | ru-486-tested | 1 |
| 617 | salt-repleted | 1 |
| 618 | sbar/49 | 1 |
| 619 | schistosoma-free | 1 |
| 620 | seafoodplus | 1 |
| 621 | self-concocted | 1 |
| 622 | sfis | 1 |
| 623 | shahrivar | 1 |
| 624 | sildenafil-naive | 1 |
| 625 | single-ovulation | 1 |
| 626 | smokers/ | 1 |
| 627 | smokers/39 | 1 |
| 628 | sr-bi-1/1 | 1 |
| 629 | starter-free | 1 |
| 630 | statin-using | 1 |
| 631 | supplement-treated | 1 |
| 632 | target-eating | 1 |
| 633 | tbz-treated | 1 |
| 634 | tdzd-8-treated | 1 |
| 635 | ten-wk-old | 1 |
| 636 | test/19 | 1 |
| 637 | tgc-treated | 1 |
| 638 | thermal-driven | 1 |
| 639 | tiadenol-treated | 1 |
| 640 | tiv-primed | 1 |
| 641 | tmd-free | 1 |
| 642 | tmp-smx-treated | 1 |
| 643 | total.300-500 | 1 |
| 644 | treated/101 | 1 |
| 645 | treatment-unchanged | 1 |
| 646 | unchallenged-unmedicated | 1 |
| 647 | unclothed | 1 |
| 648 | university-age | 1 |
| 649 | venue-recruited | 1 |
| 650 | viatromb-treated | 1 |
| 651 | vlp-vaccinated | 1 |
| 652 | weeks.in | 1 |
| 653 | weight-controlling | 1 |
| 654 | weight-trained | 1 |
| 655 | wistar-albino-type | 1 |
| 656 | wistar-han | 1 |
| 657 | women/10 | 1 |
| 658 | women/3 | 1 |
| 659 | women/6 | 1 |
| 660 | women/86 | 1 |
| 661 | women/97 | 1 |
| 662 | wt-tac | 1 |
| 663 | xbd173-dosed | 1 |
| 664 | young/adult | 1 |
| 665 | younger/normosmic | 1 |
| 666 | zairian | 1 |
| 1 | 'lowering | 1 |
| 2 | ,986 | 1 |
| 3 | 0676 | 1 |
| 4 | 1,129,025 | 1 |
| 5 | 1,790,241 | 1 |
| 6 | 1,913,925 | 1 |
| 7 | 10,101 | 4 |
| 8 | 10,229 | 1 |
| 9 | 10,462 | 1 |
| 10 | 10,463 | 1 |
| 11 | 10,486 | 2 |
| 12 | 10,672 | 1 |
| 13 | 10,756 | 1 |
| 14 | 10,814 | 1 |
| 15 | 106,406 | 1 |
| 16 | 11,116 | 1 |
| 17 | 11,554 | 1 |
| 18 | 11.114 | 2 |
| 19 | 11.5-y-old | 1 |
| 20 | 114,999 | 1 |
| 21 | 11498 | 2 |
| 22 | 119,151 | 1 |
| 23 | 11914 | 1 |
| 24 | 12,463 | 1 |
| 25 | 12,903 | 1 |
| 26 | 12-kg | 2 |
| 27 | 12-to | 2 |
| 28 | 12058 | 1 |
| 29 | 121,081 | 1 |
| 30 | 122/291 | 1 |
| 31 | 13,045 | 1 |
| 32 | 13,277 | 1 |
| 33 | 13,444 | 1 |
| 34 | 13,770 | 1 |
| 35 | 13/198 | 1 |
| 36 | 135,715 | 1 |
| 37 | 136,720 | 1 |
| 38 | 14,571 | 1 |
| 39 | 14,762 | 1 |
| 40 | 14,965 | 1 |
| 41 | 14-d-old | 4 |
| 42 | 145,007 | 1 |
| 43 | 15,005 | 1 |
| 44 | 15,150 | 2 |
| 45 | 15,261 | 2 |
| 46 | 15,366 | 1 |
| 47 | 15,419 | 1 |
| 48 | 153,996 | 1 |
| 49 | 154899 | 1 |
| 50 | 15910 | 1 |
| 51 | 16,154 | 2 |
| 52 | 16,856 | 1 |
| 53 | 16,876 | 1 |
| 54 | 162,576 | 1 |
| 55 | 166,755 | 1 |
| 56 | 16608 | 1 |
| 57 | 17,852 | 1 |
| 58 | 17-day-old | 2 |
| 59 | 17/394 | 1 |
| 60 | 17/490 | 1 |
| 61 | 170/185 | 1 |
| 62 | 174,120 | 1 |
| 63 | 176,441 | 1 |
| 64 | 176/325 | 1 |
| 65 | 176/345 | 1 |
| 66 | 18,348 | 1 |
| 67 | 18,403 | 1 |
| 68 | 18,558 | 1 |
| 69 | 18,748 | 1 |
| 70 | 18,978 | 1 |
| 71 | 188,934 | 1 |
| 72 | 19,522 | 1 |
| 73 | 19,596 | 1 |
| 74 | 19,961 | 1 |
| 75 | 193,372 | 1 |
| 76 | 2,061 | 1 |
| 77 | 2,196 | 1 |
| 78 | 2,279 | 1 |
| 79 | 2,767 | 1 |
| 80 | 2,872 | 2 |
| 81 | 2-month-to | 1 |
| 82 | 20,076 | 1 |
| 83 | 20,360 | 1 |
| 84 | 20,742 | 1 |
| 85 | 20,746 | 1 |
| 86 | 202,517 | 1 |
| 87 | 21,268 | 1 |
| 88 | 21,959 | 1 |
| 89 | 216,400 | 1 |
| 90 | 22,604 | 1 |
| 91 | 22,896 | 1 |
| 92 | 22-d-old | 2 |
| 93 | 223,336 | 1 |
| 94 | 226,877 | 1 |
| 95 | 23,508 | 1 |
| 96 | 23,661 | 1 |
| 97 | 232515 | 1 |
| 98 | 24,523 | 1 |
| 99 | 24,529 | 1 |
| 100 | 24,976 | 1 |
| 101 | 24-overweight/obese | 1 |
| 102 | 245,610 | 2 |
| 103 | 25-wk-old | 1 |
| 104 | 25.08/100,000 | 1 |
| 105 | 2526 | 2 |
| 106 | 26,224 | 1 |
| 107 | 26,272 | 1 |
| 108 | 26,599 | 1 |
| 109 | 26,703 | 1 |
| 110 | 26.18/100,000 | 1 |
| 111 | 261248 | 1 |
| 112 | 27,341 | 1 |
| 113 | 274,135 | 1 |
| 114 | 28,583 | 1 |
| 115 | 28,997 | 1 |
| 116 | 280/349 | 1 |
| 117 | 280000 | 1 |
| 118 | 282,875 | 1 |
| 119 | 285,864 | 1 |
| 120 | 29,012 | 1 |
| 121 | 29,265 | 1 |
| 122 | 29,579 | 1 |
| 123 | 29,978 | 1 |
| 124 | 3,142 | 1 |
| 125 | 3,258 | 2 |
| 126 | 3,306 | 1 |
| 127 | 3,348 | 1 |
| 128 | 3,408 | 1 |
| 129 | 3,619 | 1 |
| 130 | 3,836 | 1 |
| 131 | 3,898 | 2 |
| 132 | 3.574 | 1 |
| 133 | 3/392 | 1 |
| 134 | 30,285 | 1 |
| 135 | 322/384 | 1 |
| 136 | 33,505 | 1 |
| 137 | 34,003 | 1 |
| 138 | 35-50-year-old | 1 |
| 139 | 35-day-old | 2 |
| 140 | 35-week-old | 1 |
| 141 | 35/62 | 1 |
| 142 | 36,214 | 1 |
| 143 | 3651 | 1 |
| 144 | 368/1012 | 1 |
| 145 | 3745 | 2 |
| 146 | 3798 | 2 |
| 147 | 4,139 | 1 |
| 148 | 4,441 | 1 |
| 149 | 4,574 | 2 |
| 150 | 4,718 | 1 |
| 151 | 4,730 | 1 |
| 152 | 4,735 | 1 |
| 153 | 4-wk-old | 2 |
| 154 | 40,410 | 1 |
| 155 | 40-67-year-old | 1 |
| 156 | 4151 | 1 |
| 157 | 42,223 | 1 |
| 158 | 4221 | 3 |
| 159 | 431,718 | 1 |
| 160 | 44/91 | 1 |
| 161 | 4453 | 1 |
| 162 | 4461 | 2 |
| 163 | 453,965 | 1 |
| 164 | 46,836 | 1 |
| 165 | 488,909 | 1 |
| 166 | 49,479 | 1 |
| 167 | 492,530 | 1 |
| 168 | 5,411 | 1 |
| 169 | 5,447 | 1 |
| 170 | 5,676 | 1 |
| 171 | 5,712 | 1 |
| 172 | 5,808 | 1 |
| 173 | 5,836 | 1 |
| 174 | 5,864 | 1 |
| 175 | 5,909 | 1 |
| 176 | 5,975 | 1 |
| 177 | 50,219 | 1 |
| 178 | 50,252 | 1 |
| 179 | 51,230 | 1 |
| 180 | 5179 | 1 |
| 181 | 55,072 | 1 |
| 182 | 57,143 | 1 |
| 183 | 57,499 | 1 |
| 184 | 57,952 | 1 |
| 185 | 58,228 | 1 |
| 186 | 59,000 | 2 |
| 187 | 6,085 | 1 |
| 188 | 6,278 | 1 |
| 189 | 6,520 | 1 |
| 190 | 6,545 | 1 |
| 191 | 6,583 | 1 |
| 192 | 6,708 | 1 |
| 193 | 6,871 | 1 |
| 194 | 60/162 | 1 |
| 195 | 607/624 | 1 |
| 196 | 6129 | 1 |
| 197 | 6222 | 1 |
| 198 | 63,624 | 1 |
| 199 | 6440 | 1 |
| 200 | 65-75-year-old | 4 |
| 201 | 66,450 | 1 |
| 202 | 6605 | 2 |
| 203 | 6693 | 1 |
| 204 | 67,471 | 1 |
| 205 | 68,412 | 1 |
| 206 | 68,954 | 1 |
| 207 | 6899 | 2 |
| 208 | 69,395 | 1 |
| 209 | 7,120 | 1 |
| 210 | 7,161 | 1 |
| 211 | 7,478 | 1 |
| 212 | 7,594 | 1 |
| 213 | 7,753 | 1 |
| 214 | 7168 | 1 |
| 215 | 7196 | 1 |
| 216 | 7210 | 1 |
| 217 | 7286 | 2 |
| 218 | 7290 | 1 |
| 219 | 73-y-old | 1 |
| 220 | 7389 | 1 |
| 221 | 7569 | 1 |
| 222 | 77,447 | 1 |
| 223 | 7744 | 1 |
| 224 | 7983 | 2 |
| 225 | 8,791 | 1 |
| 226 | 8,891 | 1 |
| 227 | 8,929 | 1 |
| 228 | 8,991 | 1 |
| 229 | 81918 | 1 |
| 230 | 82,553 | 1 |
| 231 | 83,140 | 1 |
| 232 | 84,394 | 1 |
| 233 | 8407 | 1 |
| 234 | 8448 | 1 |
| 235 | 847,982 | 1 |
| 236 | 8581 | 2 |
| 237 | 8731 | 1 |
| 238 | 8802 | 1 |
| 239 | 8938 | 1 |
| 240 | 9,497 | 1 |
| 241 | 9,668 | 1 |
| 242 | 9,959 | 1 |
| 243 | 9-mo-old | 4 |
| 244 | 9/195 | 1 |
| 245 | 91,588 | 1 |
| 246 | 91,627 | 1 |
| 247 | 922/301 | 1 |
| 248 | 9393 | 1 |
| 249 | 94,808 | 1 |
| 250 | 9471 | 1 |
| 251 | 95,038 | 1 |
| 252 | 95,598 | 1 |
| 253 | 9528 | 1 |
| 254 | 9573 | 1 |
| 255 | 9690 | 1 |
| 256 | 97,486 | 1 |
| 257 | 98,093 | 1 |
| 258 | 9928 | 1 |
| 259 | acth-sufficient | 3 |
| 260 | active-dosed | 1 |
| 261 | ad5-seronegative | 2 |
| 262 | aed-treated | 1 |
| 263 | age-marched | 1 |
| 264 | age-menopause-matched | 1 |
| 265 | alcohol-dependent/abusing | 1 |
| 266 | ams-resistant | 2 |
| 267 | amygdala-implanted | 1 |
| 268 | anthocyanin-treated | 1 |
| 269 | anti-hbc-positive/hbsag-negative | 1 |
| 270 | apparently-healthy | 2 |
| 271 | artificially-inseminated | 1 |
| 272 | aspirin-naïve | 1 |
| 273 | atdh-free | 1 |
| 274 | atg/g-csf-treated | 1 |
| 275 | atropine-injected | 1 |
| 276 | attention/relaxation | 1 |
| 277 | attestable | 1 |
| 278 | avanafil-treated | 2 |
| 279 | average-height | 1 |
| 280 | bcp-treated | 1 |
| 281 | bed-confined | 1 |
| 282 | benralizumab-treated | 1 |
| 283 | bgg492-treated | 1 |
| 284 | biojector-primed | 1 |
| 285 | bisphosphonate-naïve | 1 |
| 286 | black-skinned | 1 |
| 287 | bms-986001-treated | 1 |
| 288 | bone-health-related | 1 |
| 289 | boys/31 | 1 |
| 290 | boys/34 | 1 |
| 291 | boys/nine | 1 |
| 292 | bpd/adhd | 1 |
| 293 | bromocriptine-qr-treated | 3 |
| 294 | bss-treated | 2 |
| 295 | btx-a-naive | 1 |
| 296 | bvdv-naïve | 1 |
| 297 | bzp/tfmpp-only | 1 |
| 298 | caesarean-delivered | 1 |
| 299 | cart-naive | 3 |
| 300 | cases/1,543 | 1 |
| 301 | cases/1,682 | 1 |
| 302 | cases/1119 | 1 |
| 303 | cases/30 | 1 |
| 304 | cases/33 | 2 |
| 305 | cases/436 | 1 |
| 306 | cases/575 | 1 |
| 307 | cases/60 | 1 |
| 308 | cases/66 | 1 |
| 309 | cases/676 | 1 |
| 310 | cases/778 | 1 |
| 311 | cav3dn-expressing | 1 |
| 312 | cbs-treated | 1 |
| 313 | ccnd1-amplified | 1 |
| 314 | cg-ss | 1 |
| 315 | chlamydial-infected | 1 |
| 316 | cholesterol-managing | 2 |
| 317 | clinic-care | 2 |
| 318 | club-level | 4 |
| 319 | club-standard | 1 |
| 320 | co-analyze | 1 |
| 321 | colour-matched | 1 |
| 322 | community-matched | 2 |
| 323 | cpi-1189-treated | 2 |
| 324 | cq-treated | 1 |
| 325 | crash-involved | 1 |
| 326 | creatine-supplemented | 1 |
| 327 | ctx/met-treated | 1 |
| 328 | cyp3a4*1/*1b | 2 |
| 329 | d-mph-treated | 3 |
| 330 | daily-smoking | 1 |
| 331 | delayed-switch | 2 |
| 332 | demographically-matched | 3 |
| 333 | detecting/treating | 1 |
| 334 | dhea-supplemented | 1 |
| 335 | diagnoses/all | 1 |
| 336 | dif-treated | 2 |
| 337 | dip-ex | 5 |
| 338 | dnb-exposed | 4 |
| 339 | dorzolamide-treated | 5 |
| 340 | dyslipidaemia-free | 1 |
| 341 | dyslipidemia-free | 1 |
| 342 | e-zes-treated | 1 |
| 343 | egg-sensitive | 2 |
| 344 | ei-group | 4 |
| 345 | endurance-trained | 56 |
| 346 | ergoferon-treated | 1 |
| 347 | etec-naïve | 4 |
| 348 | eusplenic | 1 |
| 349 | euthyreoid | 1 |
| 350 | evening-healthy | 1 |
| 351 | ewes/ten | 1 |
| 352 | ex101-treated | 1 |
| 353 | exposure-to-secondhand-smoke | 3 |
| 354 | female/10 | 1 |
| 355 | female/11 | 1 |
| 356 | female/14 | 1 |
| 357 | female/15 | 1 |
| 358 | female/21 | 1 |
| 359 | female/27 | 1 |
| 360 | female/51 | 1 |
| 361 | female/58 | 1 |
| 362 | female:33 | 1 |
| 363 | females/11 | 1 |
| 364 | females/14 | 1 |
| 365 | females/20 | 1 |
| 366 | females/5 | 1 |
| 367 | females/50 | 1 |
| 368 | fo-treated | 1 |
| 369 | fp-resistant | 1 |
| 370 | freeliving | 1 |
| 371 | freshly-extracted | 2 |
| 372 | fungi-free | 1 |
| 373 | gaa-supplemented | 1 |
| 374 | gc-treated | 1 |
| 375 | gender-equity-promoting | 1 |
| 376 | genistein-administered | 1 |
| 377 | girls/15 | 1 |
| 378 | girls/17 | 1 |
| 379 | grass-allergic | 2 |
| 380 | group-48 | 1 |
| 381 | h-imbibed | 2 |
| 382 | haemoglobin-a | 1 |
| 383 | hape-susceptible | 2 |
| 384 | havh-positive | 1 |
| 385 | hazardous-drinking | 2 |
| 386 | hbv-seronegative | 3 |
| 387 | hbv-seropositive | 2 |
| 388 | hdm-sensitized | 1 |
| 389 | healthy | 29,862 |
| 390 | healthy-matched | 1 |
| 391 | healty | 6 |
| 392 | heathy | 1 |
| 393 | hetg-positive | 1 |
| 394 | hg-treated | 1 |
| 395 | high-absorbency | 1 |
| 396 | highly-motivated | 1 |
| 397 | hla-a2+ | 1 |
| 398 | hsv-2-serodiscordant | 1 |
| 399 | hsv-2/hiv-1-coinfected | 1 |
| 400 | huma | 1 |
| 401 | humans.forty-two | 1 |
| 402 | hyperfibrinogenaemic | 2 |
| 403 | hypertensive/diabetic | 1 |
| 404 | hypoergic | 1 |
| 405 | identity-seeking | 1 |
| 406 | igeκ-occupied | 1 |
| 407 | igg3-ia-positive | 1 |
| 408 | int2d | 1 |
| 409 | internationally-ranked | 1 |
| 410 | intramuscular-treated | 1 |
| 411 | ivm-treated | 1 |
| 412 | jhs | 1 |
| 413 | jianyang | 1 |
| 414 | kezhuohou | 3 |
| 415 | kgf-treated | 1 |
| 416 | kulun | 3 |
| 417 | kupat | 2 |
| 418 | labyrinthine-defective | 1 |
| 419 | language-matched | 1 |
| 420 | late/ | 1 |
| 421 | latino-american | 2 |
| 422 | ldhiv | 5 |
| 423 | leptin-sensitive | 3 |
| 424 | lexaptepid-treated | 1 |
| 425 | light/non-drinking | 1 |
| 426 | lllt-treated | 3 |
| 427 | low-compliant | 1 |
| 428 | low-psa | 1 |
| 429 | low-self-deceptive | 1 |
| 430 | macitentan-treated | 1 |
| 431 | malaria-naïve | 7 |
| 432 | male/11 | 1 |
| 433 | male/13 | 1 |
| 434 | male/14 | 1 |
| 435 | male/23 | 2 |
| 436 | male/31 | 1 |
| 437 | male/7 | 3 |
| 438 | male/9 | 2 |
| 439 | male/eight | 1 |
| 440 | male/six | 1 |
| 441 | male:31 | 1 |
| 442 | males,18 | 1 |
| 443 | males,41 | 1 |
| 444 | males/10 | 4 |
| 445 | males/12 | 1 |
| 446 | males/13 | 1 |
| 447 | males/16 | 1 |
| 448 | males/18 | 1 |
| 449 | males/23 | 1 |
| 450 | males/24 | 1 |
| 451 | males/26 | 2 |
| 452 | males/37 | 1 |
| 453 | males/40 | 1 |
| 454 | males/45 | 1 |
| 455 | males/5 | 1 |
| 456 | males/7 | 2 |
| 457 | males/8 | 2 |
| 458 | males/9 | 1 |
| 459 | males/nine | 1 |
| 460 | males/thirteen | 1 |
| 461 | males:14 | 1 |
| 462 | marijuana-dependent | 21 |
| 463 | matched-healthy | 1 |
| 464 | mavrilimumab-treated | 2 |
| 465 | mbl-hcv1-treated | 2 |
| 466 | meal-fed | 1 |
| 467 | medi-534-vaccinated | 1 |
| 468 | medication-nonadherent | 1 |
| 469 | men/27 | 2 |
| 470 | micrograms-treated | 1 |
| 471 | mitraclip-treated | 1 |
| 472 | mk-3641-treated | 1 |
| 473 | mosquito-bite-sensitive | 2 |
| 474 | mtb-infected | 3 |
| 475 | multitalker | 4 |
| 476 | murid | 1 |
| 477 | naft-1-treated | 1 |
| 478 | negative-emotion | 1 |
| 479 | neighborhood-and-age-matched | 1 |
| 480 | neophyte | 6 |
| 481 | neutral/beneficial | 1 |
| 482 | niacin-naïve | 1 |
| 483 | niacin-treated | 3 |
| 484 | nineteen-year-old | 1 |
| 485 | no-memory | 1 |
| 486 | no-psychopathology | 1 |
| 487 | non-abruption | 1 |
| 488 | non-all | 2 |
| 489 | non-athletic | 5 |
| 490 | non-bd | 1 |
| 491 | non-ckdu | 6 |
| 492 | non-dandruff | 1 |
| 493 | non-ehs | 2 |
| 494 | non-eoe | 6 |
| 495 | non-fever | 1 |
| 496 | non-firefighting | 1 |
| 497 | non-heat-acclimated | 13 |
| 498 | non-hypercapnic | 1 |
| 499 | non-hyperlipidaemic | 2 |
| 500 | non-hysterectomy | 4 |
| 501 | non-ics-using | 1 |
| 502 | non-insulin-resistant | 2 |
| 503 | non-invited | 1 |
| 504 | non-late-life | 12 |
| 505 | non-lda | 1 |
| 506 | non-marsupial | 1 |
| 507 | non-minos | 2 |
| 508 | non-neurotic | 1 |
| 509 | non-oil-yielding | 1 |
| 510 | non-ow | 2 |
| 511 | non-patient | 14 |
| 512 | non-pfo | 1 |
| 513 | non-pl | 1 |
| 514 | non-rhinitic | 1 |
| 515 | non-screen | 2 |
| 516 | non-thrombocytopenic | 1 |
| 517 | non-travelling | 4 |
| 518 | non-vgp | 1 |
| 519 | nonabstaining | 3 |
| 520 | nonacclimated | 6 |
| 521 | nonhypercholesterolaemic | 1 |
| 522 | nonhyperresponsive | 1 |
| 523 | nonhysterectomized | 6 |
| 524 | nonmaltreated | 4 |
| 525 | nonmosaic | 2 |
| 526 | nonobesed | 1 |
| 527 | nonorthodontic | 1 |
| 528 | nonpolyhydramnios | 1 |
| 529 | nonsinger | 1 |
| 530 | nonstrabismic | 1 |
| 531 | nontraveling | 1 |
| 532 | nontumor-bearing | 1 |
| 533 | normal-sighted | 1 |
| 534 | normoleptinaemic | 1 |
| 535 | normotensive/pre-hypertensive | 1 |
| 536 | oc+ | 1 |
| 537 | oculo-visually | 1 |
| 538 | older/hyposmic | 1 |
| 539 | older/longer | 1 |
| 540 | op-exposed | 1 |
| 541 | opioid-injecting | 6 |
| 542 | osteiporotic | 1 |
| 543 | osteopenic/osteoporotic | 2 |
| 544 | otherwise-healthy | 4 |
| 545 | over-65-year-old | 1 |
| 546 | overtrained | 2 |
| 547 | para-suicidal | 1 |
| 548 | parolee | 1 |
| 549 | participants-12 | 1 |
| 550 | patients/11 | 1 |
| 551 | patients/12 | 1 |
| 552 | patients/31 | 1 |
| 553 | peanut-allergic | 3 |
| 554 | pegaptanib-treated | 2 |
| 555 | per-mag | 5 |
| 556 | percent.the | 1 |
| 557 | periodontally-healthy | 1 |
| 558 | periodontitis-affected | 1 |
| 559 | periodontitis-free | 2 |
| 560 | pgz-treated | 2 |
| 561 | physically-inactive | 1 |
| 562 | pib-negative | 2 |
| 563 | plants-using | 1 |
| 564 | polysomnography-monitored | 1 |
| 565 | poorly-specified | 1 |
| 566 | post-cea | 1 |
| 567 | post-coronary-bypass | 1 |
| 568 | postlingually | 14 |
| 569 | pramipexole-treated | 2 |
| 570 | pre-adolescent | 13 |
| 571 | prelingually | 1 |
| 572 | preobese | 2 |
| 573 | preschool/early | 1 |
| 574 | prevalent-hemodialysis | 1 |
| 575 | proban-treated | 1 |
| 576 | protocol-adherent | 2 |
| 577 | ptz-kindled | 5 |
| 578 | r-hprl-treated | 1 |
| 579 | r-trained | 1 |
| 580 | r53r | 4 |
| 581 | random-source | 7 |
| 582 | randomly-selected | 23 |
| 583 | rasburicase-treated | 1 |
| 584 | rate-matched | 2 |
| 585 | rcts,3097 | 1 |
| 586 | ready-to-emerge | 2 |
| 587 | rearfoot-strike | 1 |
| 588 | recreationally-trained | 1 |
| 589 | region-matched | 2 |
| 590 | resistance-trained | 51 |
| 591 | resistant/relapsed | 1 |
| 592 | rhinovirus-infected | 2 |
| 593 | rhsod-treated | 1 |
| 594 | rotation-susceptible | 1 |
| 595 | rsp-treated | 1 |
| 596 | ru-486-tested | 1 |
| 597 | saline-infused | 3 |
| 598 | salt-repleted | 1 |
| 599 | sbar/49 | 1 |
| 600 | schistosoma-free | 1 |
| 601 | seafoodplus | 1 |
| 602 | self-concocted | 1 |
| 603 | sfis | 1 |
| 604 | shahrivar | 1 |
| 605 | shep-treated | 2 |
| 606 | shirsha | 7 |
| 607 | sildenafil-naive | 1 |
| 608 | similar-aged | 5 |
| 609 | single-ovulation | 1 |
| 610 | smokers/ | 1 |
| 611 | smokers/39 | 1 |
| 612 | social-drinking | 3 |
| 613 | sodium-depleted | 4 |
| 614 | sodium-repleted | 2 |
| 615 | speech-anxious | 2 |
| 616 | spider-fearful | 4 |
| 617 | sr-bi-1/1 | 1 |
| 618 | starter-free | 1 |
| 619 | statin-using | 1 |
| 620 | supplement-treated | 1 |
| 621 | tajik | 2 |
| 622 | target-eating | 1 |
| 623 | tbz-treated | 1 |
| 624 | tdzd-8-treated | 1 |
| 625 | ten-wk-old | 1 |
| 626 | test/19 | 1 |
| 627 | tgc-treated | 1 |
| 628 | thermal-driven | 1 |
| 629 | tiadenol-treated | 1 |
| 630 | tick-infested | 3 |
| 631 | time-dated | 4 |
| 632 | tiv-primed | 1 |
| 633 | tmd-free | 1 |
| 634 | tmp-smx-treated | 1 |
| 635 | total.300-500 | 1 |
| 636 | treated/101 | 1 |
| 637 | treatment-unchanged | 1 |
| 638 | trichomonas-free | 3 |
| 639 | unchallenged-unmedicated | 1 |
| 640 | unclothed | 1 |
| 641 | undialysed | 2 |
| 642 | university-age | 1 |
| 643 | unsexed | 2 |
| 644 | venue-recruited | 1 |
| 645 | viatromb-treated | 1 |
| 646 | vlp-vaccinated | 1 |
| 647 | weeks.in | 1 |
| 648 | weight-controlling | 1 |
| 649 | weight-trained | 1 |
| 650 | wistar-albino-type | 1 |
| 651 | wistar-han | 1 |
| 652 | women/10 | 1 |
| 653 | women/3 | 1 |
| 654 | women/4 | 2 |
| 655 | women/6 | 1 |
| 656 | women/86 | 1 |
| 657 | women/97 | 1 |
| 658 | wt-tac | 1 |
| 659 | xbd173-dosed | 1 |
| 660 | young/adult | 1 |
| 661 | younger-old | 3 |
| 662 | younger/normosmic | 1 |
| 663 | yr-old | 2 |
| 664 | zairian | 1 |
| 665 | zonisamide-treated | 2 |
| 666 | °c-acclimated | 2 |
| 1 | hla-a2+ | 1 |
| 2 | oc+ | 1 |
| 3 | late/ | 1 |
| 4 | smokers/ | 1 |
| 5 | 25.08/100,000 | 1 |
| 6 | 26.18/100,000 | 1 |
| 7 | 59,000 | 2 |
| 8 | 280000 | 1 |
| 9 | 216,400 | 1 |
| 10 | total.300-500 | 1 |
| 11 | female/10 | 1 |
| 12 | women/10 | 1 |
| 13 | males/10 | 4 |
| 14 | 7210 | 1 |
| 15 | 40,410 | 1 |
| 16 | 245,610 | 2 |
| 17 | 15910 | 1 |
| 18 | females/20 | 1 |
| 19 | 174,120 | 1 |
| 20 | 7,120 | 1 |
| 21 | 6,520 | 1 |
| 22 | 136,720 | 1 |
| 23 | cases/30 | 1 |
| 24 | 51,230 | 1 |
| 25 | 492,530 | 1 |
| 26 | 4,730 | 1 |
| 27 | males/40 | 1 |
| 28 | 83,140 | 1 |
| 29 | 6440 | 1 |
| 30 | females/50 | 1 |
| 31 | 15,150 | 2 |
| 32 | 66,450 | 1 |
| 33 | cases/60 | 1 |
| 34 | 20,360 | 1 |
| 35 | 13,770 | 1 |
| 36 | 7290 | 1 |
| 37 | 17/490 | 1 |
| 38 | 9690 | 1 |
| 39 | sr-bi-1/1 | 1 |
| 40 | 10,101 | 4 |
| 41 | treated/101 | 1 |
| 42 | 922/301 | 1 |
| 43 | male/11 | 1 |
| 44 | female/11 | 1 |
| 45 | females/11 | 1 |
| 46 | patients/11 | 1 |
| 47 | 5,411 | 1 |
| 48 | female/21 | 1 |
| 49 | 4221 | 3 |
| 50 | male/31 | 1 |
| 51 | patients/31 | 1 |
| 52 | boys/31 | 1 |
| 53 | 8731 | 1 |
| 54 | male:31 | 1 |
| 55 | males,41 | 1 |
| 56 | 1,790,241 | 1 |
| 57 | 27,341 | 1 |
| 58 | 4,441 | 1 |
| 59 | 176,441 | 1 |
| 60 | female/51 | 1 |
| 61 | 119,151 | 1 |
| 62 | 4151 | 1 |
| 63 | 3651 | 1 |
| 64 | 2,061 | 1 |
| 65 | 7,161 | 1 |
| 66 | 15,261 | 2 |
| 67 | 4461 | 2 |
| 68 | 23,661 | 1 |
| 69 | 19,961 | 1 |
| 70 | 67,471 | 1 |
| 71 | 9471 | 1 |
| 72 | 14,571 | 1 |
| 73 | 6,871 | 1 |
| 74 | 121,081 | 1 |
| 75 | 8581 | 2 |
| 76 | 44/91 | 1 |
| 77 | 122/291 | 1 |
| 78 | 8,791 | 1 |
| 79 | 8,891 | 1 |
| 80 | 8,991 | 1 |
| 81 | 8802 | 1 |
| 82 | participants-12 | 1 |
| 83 | males/12 | 1 |
| 84 | patients/12 | 1 |
| 85 | 29,012 | 1 |
| 86 | 368/1012 | 1 |
| 87 | 68,412 | 1 |
| 88 | 5,712 | 1 |
| 89 | 6222 | 1 |
| 90 | 19,522 | 1 |
| 91 | 3,142 | 1 |
| 92 | 20,742 | 1 |
| 93 | 50,252 | 1 |
| 94 | 17,852 | 1 |
| 95 | 57,952 | 1 |
| 96 | 35/62 | 1 |
| 97 | 60/162 | 1 |
| 98 | 10,462 | 1 |
| 99 | 14,762 | 1 |
| 100 | 55,072 | 1 |
| 101 | 26,272 | 1 |
| 102 | 193,372 | 1 |
| 103 | 10,672 | 1 |
| 104 | 2,872 | 2 |
| 105 | cases/1,682 | 1 |
| 106 | 847,982 | 1 |
| 107 | 3/392 | 1 |
| 108 | women/3 | 1 |
| 109 | 34,003 | 1 |
| 110 | 18,403 | 1 |
| 111 | 26,703 | 1 |
| 112 | 12,903 | 1 |
| 113 | male/13 | 1 |
| 114 | males/13 | 1 |
| 115 | male/23 | 2 |
| 116 | males/23 | 1 |
| 117 | 42,223 | 1 |
| 118 | 24,523 | 1 |
| 119 | cases/33 | 2 |
| 120 | female:33 | 1 |
| 121 | 57,143 | 1 |
| 122 | cases/1,543 | 1 |
| 123 | 4453 | 1 |
| 124 | 82,553 | 1 |
| 125 | 7,753 | 1 |
| 126 | 10,463 | 1 |
| 127 | 12,463 | 1 |
| 128 | 9573 | 1 |
| 129 | 6,583 | 1 |
| 130 | 28,583 | 1 |
| 131 | 7983 | 2 |
| 132 | 98,093 | 1 |
| 133 | 9393 | 1 |
| 134 | 6693 | 1 |
| 135 | women/4 | 2 |
| 136 | 22,604 | 1 |
| 137 | male/14 | 1 |
| 138 | female/14 | 1 |
| 139 | females/14 | 1 |
| 140 | 11.114 | 2 |
| 141 | 36,214 | 1 |
| 142 | 10,814 | 1 |
| 143 | 11914 | 1 |
| 144 | males:14 | 1 |
| 145 | males/24 | 1 |
| 146 | 26,224 | 1 |
| 147 | 63,624 | 1 |
| 148 | 607/624 | 1 |
| 149 | boys/34 | 1 |
| 150 | 188,934 | 1 |
| 151 | 13,444 | 1 |
| 152 | 7744 | 1 |
| 153 | 16,154 | 2 |
| 154 | 11,554 | 1 |
| 155 | 68,954 | 1 |
| 156 | 5,864 | 1 |
| 157 | 285,864 | 1 |
| 158 | 4,574 | 2 |
| 159 | 3.574 | 1 |
| 160 | 322/384 | 1 |
| 161 | 84,394 | 1 |
| 162 | 17/394 | 1 |
| 163 | 7,594 | 1 |
| 164 | males/5 | 1 |
| 165 | females/5 | 1 |
| 166 | 15,005 | 1 |
| 167 | 33,505 | 1 |
| 168 | 6605 | 2 |
| 169 | female/15 | 1 |
| 170 | girls/15 | 1 |
| 171 | 232515 | 1 |
| 172 | 135,715 | 1 |
| 173 | 1,129,025 | 1 |
| 174 | 176/325 | 1 |
| 175 | 1,913,925 | 1 |
| 176 | 274,135 | 1 |
| 177 | 4,735 | 1 |
| 178 | males/45 | 1 |
| 179 | 13,045 | 1 |
| 180 | 176/345 | 1 |
| 181 | 6,545 | 1 |
| 182 | 3745 | 2 |
| 183 | 166,755 | 1 |
| 184 | 29,265 | 1 |
| 185 | 453,965 | 1 |
| 186 | 14,965 | 1 |
| 187 | cases/575 | 1 |
| 188 | 282,875 | 1 |
| 189 | 5,975 | 1 |
| 190 | 6,085 | 1 |
| 191 | 170/185 | 1 |
| 192 | 30,285 | 1 |
| 193 | 9/195 | 1 |
| 194 | 69,395 | 1 |
| 195 | women/6 | 1 |
| 196 | 3,306 | 1 |
| 197 | 106,406 | 1 |
| 198 | males/16 | 1 |
| 199 | 11,116 | 1 |
| 200 | males/26 | 2 |
| 201 | 2526 | 2 |
| 202 | 223,336 | 1 |
| 203 | cases/436 | 1 |
| 204 | 3,836 | 1 |
| 205 | 5,836 | 1 |
| 206 | 46,836 | 1 |
| 207 | 20,746 | 1 |
| 208 | 10,756 | 1 |
| 209 | 16,856 | 1 |
| 210 | cases/66 | 1 |
| 211 | 15,366 | 1 |
| 212 | 20,076 | 1 |
| 213 | 162,576 | 1 |
| 214 | 5,676 | 1 |
| 215 | cases/676 | 1 |
| 216 | 0676 | 1 |
| 217 | 16,876 | 1 |
| 218 | 24,976 | 1 |
| 219 | women/86 | 1 |
| 220 | 7286 | 2 |
| 221 | 10,486 | 2 |
| 222 | 97,486 | 1 |
| 223 | ,986 | 1 |
| 224 | 2,196 | 1 |
| 225 | 7196 | 1 |
| 226 | 19,596 | 1 |
| 227 | 22,896 | 1 |
| 228 | 153,996 | 1 |
| 229 | male/7 | 3 |
| 230 | males/7 | 2 |
| 231 | 145,007 | 1 |
| 232 | 8407 | 1 |
| 233 | girls/17 | 1 |
| 234 | 202,517 | 1 |
| 235 | female/27 | 1 |
| 236 | men/27 | 2 |
| 237 | 91,627 | 1 |
| 238 | males/37 | 1 |
| 239 | 5,447 | 1 |
| 240 | 77,447 | 1 |
| 241 | 2,767 | 1 |
| 242 | 13,277 | 1 |
| 243 | 226,877 | 1 |
| 244 | women/97 | 1 |
| 245 | rcts,3097 | 1 |
| 246 | 9,497 | 1 |
| 247 | 28,997 | 1 |
| 248 | males/8 | 2 |
| 249 | 3,408 | 1 |
| 250 | 23,508 | 1 |
| 251 | 16608 | 1 |
| 252 | 6,708 | 1 |
| 253 | 94,808 | 1 |
| 254 | 5,808 | 1 |
| 255 | males,18 | 1 |
| 256 | males/18 | 1 |
| 257 | 431,718 | 1 |
| 258 | 4,718 | 1 |
| 259 | 81918 | 1 |
| 260 | 58,228 | 1 |
| 261 | 9528 | 1 |
| 262 | 9928 | 1 |
| 263 | 95,038 | 1 |
| 264 | 8938 | 1 |
| 265 | group-48 | 1 |
| 266 | 261248 | 1 |
| 267 | 3,348 | 1 |
| 268 | 18,348 | 1 |
| 269 | 8448 | 1 |
| 270 | 18,748 | 1 |
| 271 | female/58 | 1 |
| 272 | 12058 | 1 |
| 273 | 3,258 | 2 |
| 274 | 18,558 | 1 |
| 275 | 7168 | 1 |
| 276 | 21,268 | 1 |
| 277 | 9,668 | 1 |
| 278 | 6,278 | 1 |
| 279 | 7,478 | 1 |
| 280 | cases/778 | 1 |
| 281 | 18,978 | 1 |
| 282 | 29,978 | 1 |
| 283 | 91,588 | 1 |
| 284 | 13/198 | 1 |
| 285 | 11498 | 2 |
| 286 | 95,598 | 1 |
| 287 | 3798 | 2 |
| 288 | 3,898 | 2 |
| 289 | male/9 | 2 |
| 290 | males/9 | 1 |
| 291 | 5,909 | 1 |
| 292 | 488,909 | 1 |
| 293 | test/19 | 1 |
| 294 | cases/1119 | 1 |
| 295 | 50,219 | 1 |
| 296 | 15,419 | 1 |
| 297 | 3,619 | 1 |
| 298 | 6129 | 1 |
| 299 | 10,229 | 1 |
| 300 | 24,529 | 1 |
| 301 | 8,929 | 1 |
| 302 | smokers/39 | 1 |
| 303 | 4,139 | 1 |
| 304 | sbar/49 | 1 |
| 305 | 280/349 | 1 |
| 306 | 21,959 | 1 |
| 307 | 9,959 | 1 |
| 308 | 7569 | 1 |
| 309 | 5179 | 1 |
| 310 | 2,279 | 1 |
| 311 | 49,479 | 1 |
| 312 | 29,579 | 1 |
| 313 | 7389 | 1 |
| 314 | 57,499 | 1 |
| 315 | 26,599 | 1 |
| 316 | 154899 | 1 |
| 317 | 6899 | 2 |
| 318 | 114,999 | 1 |
| 319 | haemoglobin-a | 1 |
| 320 | non-lda | 1 |
| 321 | post-cea | 1 |
| 322 | shirsha | 7 |
| 323 | huma | 1 |
| 324 | low-psa | 1 |
| 325 | cyp3a4*1/*1b | 2 |
| 326 | wt-tac | 1 |
| 327 | nonmosaic | 2 |
| 328 | grass-allergic | 2 |
| 329 | peanut-allergic | 3 |
| 330 | hypoergic | 1 |
| 331 | non-hyperlipidaemic | 2 |
| 332 | nonhypercholesterolaemic | 1 |
| 333 | hyperfibrinogenaemic | 2 |
| 334 | normoleptinaemic | 1 |
| 335 | nonstrabismic | 1 |
| 336 | younger/normosmic | 1 |
| 337 | older/hyposmic | 1 |
| 338 | eusplenic | 1 |
| 339 | non-thrombocytopenic | 1 |
| 340 | non-hypercapnic | 1 |
| 341 | hypertensive/diabetic | 1 |
| 342 | non-athletic | 5 |
| 343 | non-rhinitic | 1 |
| 344 | nonorthodontic | 1 |
| 345 | osteiporotic | 1 |
| 346 | osteopenic/osteoporotic | 2 |
| 347 | non-neurotic | 1 |
| 348 | int2d | 1 |
| 349 | non-bd | 1 |
| 350 | h-imbibed | 2 |
| 351 | meal-fed | 1 |
| 352 | similar-aged | 5 |
| 353 | treatment-unchanged | 1 |
| 354 | age-marched | 1 |
| 355 | neighborhood-and-age-matched | 1 |
| 356 | language-matched | 1 |
| 357 | age-menopause-matched | 1 |
| 358 | rate-matched | 2 |
| 359 | region-matched | 2 |
| 360 | colour-matched | 1 |
| 361 | healthy-matched | 1 |
| 362 | demographically-matched | 3 |
| 363 | community-matched | 2 |
| 364 | unclothed | 1 |
| 365 | poorly-specified | 1 |
| 366 | ccnd1-amplified | 1 |
| 367 | igeκ-occupied | 1 |
| 368 | internationally-ranked | 1 |
| 369 | ptz-kindled | 5 |
| 370 | biojector-primed | 1 |
| 371 | tiv-primed | 1 |
| 372 | endurance-trained | 56 |
| 373 | resistance-trained | 51 |
| 374 | r-trained | 1 |
| 375 | weight-trained | 1 |
| 376 | recreationally-trained | 1 |
| 377 | overtrained | 2 |
| 378 | bed-confined | 1 |
| 379 | black-skinned | 1 |
| 380 | genistein-administered | 1 |
| 381 | caesarean-delivered | 1 |
| 382 | polysomnography-monitored | 1 |
| 383 | nonobesed | 1 |
| 384 | xbd173-dosed | 1 |
| 385 | active-dosed | 1 |
| 386 | dnb-exposed | 4 |
| 387 | op-exposed | 1 |
| 388 | resistant/relapsed | 1 |
| 389 | saline-infused | 3 |
| 390 | undialysed | 2 |
| 391 | unchallenged-unmedicated | 1 |
| 392 | time-dated | 4 |
| 393 | naft-1-treated | 1 |
| 394 | bms-986001-treated | 1 |
| 395 | ex101-treated | 1 |
| 396 | mk-3641-treated | 1 |
| 397 | mbl-hcv1-treated | 2 |
| 398 | bgg492-treated | 1 |
| 399 | tdzd-8-treated | 1 |
| 400 | cpi-1189-treated | 2 |
| 401 | mavrilimumab-treated | 2 |
| 402 | benralizumab-treated | 1 |
| 403 | pegaptanib-treated | 2 |
| 404 | viatromb-treated | 1 |
| 405 | gc-treated | 1 |
| 406 | tgc-treated | 1 |
| 407 | aed-treated | 1 |
| 408 | lexaptepid-treated | 1 |
| 409 | rhsod-treated | 1 |
| 410 | dorzolamide-treated | 5 |
| 411 | zonisamide-treated | 2 |
| 412 | pramipexole-treated | 2 |
| 413 | rasburicase-treated | 1 |
| 414 | kgf-treated | 1 |
| 415 | dif-treated | 2 |
| 416 | atg/g-csf-treated | 1 |
| 417 | hg-treated | 1 |
| 418 | d-mph-treated | 3 |
| 419 | avanafil-treated | 2 |
| 420 | tiadenol-treated | 1 |
| 421 | r-hprl-treated | 1 |
| 422 | ivm-treated | 1 |
| 423 | proban-treated | 1 |
| 424 | macitentan-treated | 1 |
| 425 | niacin-treated | 3 |
| 426 | anthocyanin-treated | 1 |
| 427 | ergoferon-treated | 1 |
| 428 | fo-treated | 1 |
| 429 | bcp-treated | 1 |
| 430 | shep-treated | 2 |
| 431 | mitraclip-treated | 1 |
| 432 | rsp-treated | 1 |
| 433 | cq-treated | 1 |
| 434 | intramuscular-treated | 1 |
| 435 | bromocriptine-qr-treated | 3 |
| 436 | cbs-treated | 1 |
| 437 | e-zes-treated | 1 |
| 438 | micrograms-treated | 1 |
| 439 | bss-treated | 2 |
| 440 | ctx/met-treated | 1 |
| 441 | lllt-treated | 3 |
| 442 | supplement-treated | 1 |
| 443 | tmp-smx-treated | 1 |
| 444 | tbz-treated | 1 |
| 445 | pgz-treated | 2 |
| 446 | nonmaltreated | 4 |
| 447 | bone-health-related | 1 |
| 448 | °c-acclimated | 2 |
| 449 | non-heat-acclimated | 13 |
| 450 | nonacclimated | 6 |
| 451 | medi-534-vaccinated | 1 |
| 452 | vlp-vaccinated | 1 |
| 453 | artificially-inseminated | 1 |
| 454 | highly-motivated | 1 |
| 455 | freshly-extracted | 2 |
| 456 | periodontitis-affected | 1 |
| 457 | mtb-infected | 3 |
| 458 | chlamydial-infected | 1 |
| 459 | rhinovirus-infected | 2 |
| 460 | hsv-2/hiv-1-coinfected | 1 |
| 461 | atropine-injected | 1 |
| 462 | randomly-selected | 23 |
| 463 | self-concocted | 1 |
| 464 | sodium-depleted | 4 |
| 465 | sodium-repleted | 2 |
| 466 | salt-repleted | 1 |
| 467 | normal-sighted | 1 |
| 468 | venue-recruited | 1 |
| 469 | non-invited | 1 |
| 470 | amygdala-implanted | 1 |
| 471 | gaa-supplemented | 1 |
| 472 | dhea-supplemented | 1 |
| 473 | creatine-supplemented | 1 |
| 474 | tick-infested | 3 |
| 475 | ru-486-tested | 1 |
| 476 | crash-involved | 1 |
| 477 | unsexed | 2 |
| 478 | nonhysterectomized | 6 |
| 479 | hdm-sensitized | 1 |
| 480 | bpd/adhd | 1 |
| 481 | euthyreoid | 1 |
| 482 | murid | 1 |
| 483 | 22-d-old | 2 |
| 484 | 14-d-old | 4 |
| 485 | 35-week-old | 1 |
| 486 | 4-wk-old | 2 |
| 487 | 25-wk-old | 1 |
| 488 | ten-wk-old | 1 |
| 489 | 9-mo-old | 4 |
| 490 | 35-50-year-old | 1 |
| 491 | over-65-year-old | 1 |
| 492 | 65-75-year-old | 4 |
| 493 | 40-67-year-old | 1 |
| 494 | nineteen-year-old | 1 |
| 495 | younger-old | 3 |
| 496 | yr-old | 2 |
| 497 | 73-y-old | 1 |
| 498 | 11.5-y-old | 1 |
| 499 | 35-day-old | 2 |
| 500 | 17-day-old | 2 |
| 501 | club-standard | 1 |
| 502 | random-source | 7 |
| 503 | parolee | 1 |
| 504 | dyslipidaemia-free | 1 |
| 505 | dyslipidemia-free | 1 |
| 506 | schistosoma-free | 1 |
| 507 | tmd-free | 1 |
| 508 | atdh-free | 1 |
| 509 | fungi-free | 1 |
| 510 | starter-free | 1 |
| 511 | trichomonas-free | 3 |
| 512 | periodontitis-free | 2 |
| 513 | non-late-life | 12 |
| 514 | university-age | 1 |
| 515 | ready-to-emerge | 2 |
| 516 | percent.the | 1 |
| 517 | rearfoot-strike | 1 |
| 518 | exposure-to-secondhand-smoke | 3 |
| 519 | attestable | 1 |
| 520 | hape-susceptible | 2 |
| 521 | rotation-susceptible | 1 |
| 522 | males/nine | 1 |
| 523 | boys/nine | 1 |
| 524 | non-eoe | 6 |
| 525 | wistar-albino-type | 1 |
| 526 | clinic-care | 2 |
| 527 | 24-overweight/obese | 1 |
| 528 | preobese | 2 |
| 529 | neophyte | 6 |
| 530 | btx-a-naive | 1 |
| 531 | sildenafil-naive | 1 |
| 532 | cart-naive | 3 |
| 533 | normotensive/pre-hypertensive | 1 |
| 534 | nonhyperresponsive | 1 |
| 535 | pib-negative | 2 |
| 536 | anti-hbc-positive/hbsag-negative | 1 |
| 537 | ad5-seronegative | 2 |
| 538 | hbv-seronegative | 3 |
| 539 | physically-inactive | 1 |
| 540 | labyrinthine-defective | 1 |
| 541 | mosquito-bite-sensitive | 2 |
| 542 | egg-sensitive | 2 |
| 543 | leptin-sensitive | 3 |
| 544 | igg3-ia-positive | 1 |
| 545 | hetg-positive | 1 |
| 546 | havh-positive | 1 |
| 547 | hbv-seropositive | 2 |
| 548 | low-self-deceptive | 1 |
| 549 | malaria-naïve | 7 |
| 550 | etec-naïve | 4 |
| 551 | bisphosphonate-naïve | 1 |
| 552 | niacin-naïve | 1 |
| 553 | aspirin-naïve | 1 |
| 554 | bvdv-naïve | 1 |
| 555 | co-analyze | 1 |
| 556 | non-dandruff | 1 |
| 557 | per-mag | 5 |
| 558 | 12-kg | 2 |
| 559 | jianyang | 1 |
| 560 | non-oil-yielding | 1 |
| 561 | cholesterol-managing | 2 |
| 562 | identity-seeking | 1 |
| 563 | social-drinking | 3 |
| 564 | light/non-drinking | 1 |
| 565 | hazardous-drinking | 2 |
| 566 | daily-smoking | 1 |
| 567 | nontraveling | 1 |
| 568 | non-travelling | 4 |
| 569 | weight-controlling | 1 |
| 570 | nonabstaining | 3 |
| 571 | nontumor-bearing | 1 |
| 572 | 'lowering | 1 |
| 573 | cav3dn-expressing | 1 |
| 574 | statin-using | 1 |
| 575 | non-ics-using | 1 |
| 576 | plants-using | 1 |
| 577 | alcohol-dependent/abusing | 1 |
| 578 | target-eating | 1 |
| 579 | detecting/treating | 1 |
| 580 | opioid-injecting | 6 |
| 581 | non-firefighting | 1 |
| 582 | gender-equity-promoting | 1 |
| 583 | freeliving | 1 |
| 584 | delayed-switch | 2 |
| 585 | tajik | 2 |
| 586 | para-suicidal | 1 |
| 587 | neutral/beneficial | 1 |
| 588 | non-marsupial | 1 |
| 589 | club-level | 4 |
| 590 | non-all | 2 |
| 591 | diagnoses/all | 1 |
| 592 | non-pl | 1 |
| 593 | spider-fearful | 4 |
| 594 | latino-american | 2 |
| 595 | wistar-han | 1 |
| 596 | zairian | 1 |
| 597 | non-screen | 2 |
| 598 | males/thirteen | 1 |
| 599 | ewes/ten | 1 |
| 600 | thermal-driven | 1 |
| 601 | weeks.in | 1 |
| 602 | single-ovulation | 1 |
| 603 | attention/relaxation | 1 |
| 604 | negative-emotion | 1 |
| 605 | non-abruption | 1 |
| 606 | kulun | 3 |
| 607 | non-pfo | 1 |
| 608 | 12-to | 2 |
| 609 | 2-month-to | 1 |
| 610 | humans.forty-two | 1 |
| 611 | non-vgp | 1 |
| 612 | ei-group | 4 |
| 613 | r53r | 4 |
| 614 | shahrivar | 1 |
| 615 | nonsinger | 1 |
| 616 | older/longer | 1 |
| 617 | multitalker | 4 |
| 618 | non-fever | 1 |
| 619 | non-ehs | 2 |
| 620 | jhs | 1 |
| 621 | sfis | 1 |
| 622 | prevalent-hemodialysis | 1 |
| 623 | nonpolyhydramnios | 1 |
| 624 | non-minos | 2 |
| 625 | cg-ss | 1 |
| 626 | post-coronary-bypass | 1 |
| 627 | seafoodplus | 1 |
| 628 | speech-anxious | 2 |
| 629 | kupat | 2 |
| 630 | male/eight | 1 |
| 631 | average-height | 1 |
| 632 | young/adult | 1 |
| 633 | hsv-2-serodiscordant | 1 |
| 634 | low-compliant | 1 |
| 635 | non-insulin-resistant | 2 |
| 636 | fp-resistant | 1 |
| 637 | ams-resistant | 2 |
| 638 | pre-adolescent | 13 |
| 639 | marijuana-dependent | 21 |
| 640 | acth-sufficient | 3 |
| 641 | non-patient | 14 |
| 642 | protocol-adherent | 2 |
| 643 | medication-nonadherent | 1 |
| 644 | non-ckdu | 6 |
| 645 | kezhuohou | 3 |
| 646 | ldhiv | 5 |
| 647 | non-ow | 2 |
| 648 | dip-ex | 5 |
| 649 | male/six | 1 |
| 650 | high-absorbency | 1 |
| 651 | no-psychopathology | 1 |
| 652 | heathy | 1 |
| 653 | healthy | 29,862 |
| 654 | matched-healthy | 1 |
| 655 | otherwise-healthy | 4 |
| 656 | evening-healthy | 1 |
| 657 | periodontally-healthy | 1 |
| 658 | apparently-healthy | 2 |
| 659 | prelingually | 1 |
| 660 | postlingually | 14 |
| 661 | oculo-visually | 1 |
| 662 | bzp/tfmpp-only | 1 |
| 663 | preschool/early | 1 |
| 664 | non-hysterectomy | 4 |
| 665 | no-memory | 1 |
| 666 | healty | 6 |